研究業績｜分子標的病理プロジェクト

原著論文

2012年｜2011年｜2010年｜2009年｜2008年｜2007年｜2006年

2012年

Kimura, H., Nakajima, T., Takeuchi, K., Soda, M., Mano, H., Iizasa, T., Matsui, Y., Yoshino, M., Shingyoji, M., Itakura, M., Itami, M., Ikebe, D., Yokoi, S., Kageyama, H., Ohira, M., Nakagawara, A.: ALK fusion gene positive lung cancer and 3 cases treated with an inhibitor for ALK kinase activity.
Lung Cancer, 75, 66-72 (2012)
Nishimori, H., Maeda, Y., Teshima, T., Sugiyama, H., Kobayashi, K., Yamasuji, Y., Kadohisa, S., Uryu, H., Takeuchi, K., Tanaka, T., Yoshino, T., Iwakura, Y., Tanimoto, M.: Synthetic retinoid Am80 ameliorates chronic graft-versus-host disease by down-regulating Th1 and Th17.
Blood, 119, 285-295 (2012)
Sugawara, E., Togashi, Y., Kuroda, N., Sakata, S., Hatano, S., Asaka, R., Yuasa, T., Yonese, J., Kitagawa, M., Mano, H., Ishikawa, Y., Takeuchi, K.: Identification of anaplastic lymphoma kinase fusions in renal cancer.
Cancer, in press (2012)
Takeuchi, K., Soda, M., Togashi, Y., Suzuki, R., Sakata, S., Hatano, S., Asaka, R., Hamanaka, W., Ninomiya, H., Uehara, H., Lim Choi, Y., Satoh, Y., Okumura, S., Nakagawa, K., Mano, H., Ishikawa, Y.: RET, ROS1 and ALK fusions in lung cancer.
Nat Med, in press (2012)
Terasako, K., Oshima, K., Wada, H., Ishihara, Y., Kawamura, K., Sakamoto, K., Ashizawa, M., Sato, M., Machishima, T., Nakasone, H., Kimura, S., Kikuchi, M., Okuda, S., Kako, S., Yamazaki, R., Takeuchi, K., Nishida, J., Yamada, S., Tanaka, O., Kanda, Y.: Fulminant hepatic failure caused by adenovirus infection mimicking peliosis hepatitis on abdominal computed tomography images after allogeneic hematopoietic stem cell transplantation.
Intern Med, 51, 405-411 (2012)
Togashi, Y., Soda, M., Sakata, S., Sugawara, E., Hatano, S., Asaka, R., Nakajima, T., Mano, H., Takeuch, K.: KLC1-ALK: A novel fusion in lung cancer identified using a formalin-fixed paraffin-embedded tissue only.
PLoS One, 7, e31323 (2012)
Tomita, N., Yokoyama, M., Yamamoto, W., Watanabe, R., Shimazu, Y., Masaki, Y., Tsunoda, S., Hashimoto, C., Murayama, K., Yano, T., Okamoto, R., Kikuchi, A., Tamura, K., Sato, K., Sunami, K., Shibayama, H., Takimoto, R., Ohshima, R., Hatta, Y., Moriuchi, Y., Kinoshita, T., Yamamoto, M., Numata, A., Ishigatsubo, Y., Takeuchi, K.: Central nervous system event in patients with diffuse large B-cell lymphoma in the rituximab era.
Cancer Sci, 103, 245-251 (2012)
Yamamoto, M., Takeuchi, K., Shimoji, M., Maniwa, T., Isaka, M., Nakagawa, K., Ohde, Y., Kondo, H., Nakajima, T.: Small non-mucinous bronchioloalveolar carcinoma with anaplastic lymphoma kinase immunoreactivity: A novel ALK fusion gene?
Cancer Sci, 103, 390-392 (2012)
Yao, R., Natsume, Y., Saiki, Y., Shioya, H., Takeuchi, K., Yamori, T., Toki, H., Aoki, I., Saga, T., Noda, T.: Disruption of Tacc3 function leads to in vivo tumor regression.
Oncogene, 31, 135-148 (2012)

2011年

Goyama, S., Takeuchi, K., Kanda, Y., Nannya, Y., Chiba, S., Fukayama, M., Kurokawa, M.: Post-transplant endothelial disorder after hematopoietic SCT: a blinded autopsy study.
Bone Marrow Transplant, in press (2011)
Kijima, T., Takeuchi, K., Tetsumoto, S., Shimada, K., Takahashi, R., Hirata, H., Nagatomo, I., Hoshino, S., Takeda, Y., Kida, H., Goya, S., Tachibana, I., Kawase, I.: Favorable response to crizotinib in three patients with echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase fusion-type oncogene-positive non-small cell lung cancer.
Cancer Sci, 102, 1602-1604 (2011)
Mishima, Y., Terui, Y., Takeuchi, K., Matsumoto-Mishima, Y., Matsusaka, S.: The identification of irreversible rituximab-resistant lymphoma caused by CD20 gene mutations.
Blood Cancer J, 1, e15 (2011)
Okuda, C., Kim, Y.H., Takeuchi, K., Togashi, Y., Masago, K., Sakamori, Y., Mio, T., Mishima, M.: Successful treatment with pemetrexed in a patient with mucinous bronchioloalveolar carcinoma: long-term response duration with mild toxicity.
J Thorac Oncol, 6, 641-642 (2011)
Tachibana, T., Tomita, N., Furuya, M., Yamanaka, S., Takeuchi, K., Nakamura, N., Fujita, H., Ishigatsubo, Y.: Aberrant CD20 Expression in Angioimmunoblastic T-cell Lymphoma.
Intern Med, 50, 495-499 (2011)
Takeuchi, K., Soda, M., Togashi, Y., Ota, Y., Sekiguchi, Y., Hatano, S., Asaka, R., Noguchi, M., Mano, H.: Identification of a novel fusion, SQSTM1-ALK, in ALK-positive large B-cell lymphoma.
Haematologica, 96, 464-467 (2011)
Takeuchi, K., Soda, M., Togashi, Y., Sugawara, E., Hatano, S., Asaka, R., Okumura, S., Nakagawa, K., Mano, H., Ishikawa, Y.: Pulmonary inflammatory myofibroblastic tumor expressing a novel fusion, PPFIBP1-ALK: reappraisal of anti-ALK immunohistochemistry as a tool for novel ALK-fusion identification.
Clin Cancer Res, 17, 3341-3348 (2011)
Tanimoto, T., Matayoshi, T., Yagasaki, F., Takeuchi, K., Kami, M.: Safety and efficacy of zoledronic acid in multiple myeloma.
Lancet, 377, 2178 (2011)
Watanabe, N., Noh, J.Y., Narimatsu, H., Takeuchi, K., Yamaguchi, T., Kameyama, K., Kobayashi, K., Kami, M., Kubo, A., Kunii, Y., Shimizu, T., Mukasa, K., Otsuka, F., Miyara, A., Minagawa, A., Ito, K.: Clinicopathological features of 171 cases of primary thyroid lymphoma: a long-term study involving 24 553 patients with Hashimoto's disease.
Br J Haematol, 153, 236-243 (2011)
Watanabe, T., Tobinai, K., Shibata, T., Tsukasaki, K., Morishima, Y., Maseki, N., Kinoshita, T., Suzuki, T., Yamaguchi, M., Ando, K., Ogura, M., Taniwaki, M., Uike, N., Takeuchi, K., Nawano, S., Terauchi, T., Hotta, T.: Phase II/III study of R-CHOP-21 versus R-CHOP-14 for untreated indolent B-Cell non-Hodgkin's lymphoma: JCOG 0203 Trial.
J Clin Oncol, 29, 3990-3998 (2011)

2010年

Asai, H., Yokoyama, M., Terui, Y., Ennishi, D., Takeuchi, K., Hatake, K.: Is statin use really associated with efficacy of rituximab?
J Clin Oncol, 28, e424-425; author reply e427-428 (2010)
Choi, Y.L., Soda, M., Yamashita, Y., Ueno, T., Takashima, J., Nakajima, T., Yatabe, Y., Takeuchi, K., Hamada, T., Haruta, H., Ishikawa, Y., Kimura, H., Mitsudomi, T., Tanio, Y., Mano, H.: EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors.
N Engl JMed, 363, 1734-1739 (2010)
Ennishi, D., Asai, H., Maeda, Y., Shinagawa, K., Ikeda, K., Yokoyama, M., Terui, Y., Takeuchi, K., Yoshino, T., Matsuo, K., Hatake, K., Tanimoto, M.: Statin-independent prognosis of patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy.
Ann Oncol, 21, 1217-1221 (2010)
Hiramatsu, M., Ninomiya, H., Inamura, K., Nomura, K., Takeuchi, K., Satoh, Y., Okumura, S., Nakagawa, K., Yamori, T., Matsuura, M., Morikawa, T., Ishikawa, Y.: Activation status of receptor tyrosine kinase downstream pathways in primary lung adenocarcinoma with reference of KRAS and EGFR mutations.
Lung Cancer, 70, 94-102 (2010)
Hoshi, R., Furuta, N., Horai, T., Takeuchi, K., Ishikawa, Y., Satoh, Y.: Implications for differential diagnosis of lung cancer-associated lymphadenopathy in lymphoepithelioid cell lymphoma (Lennert's lymphoma) arising simultaneously with lung cancer: a case report.
Acta Cytol, 54, 197-201 (2010)
Hyo, R., Tomita, N., Takeuchi, K., Aoshima, T., Fujita, A., Kuwabara, H., Hashimoto, C., Takemura, S., Taguchi, J., Sakai, R., Fujita, H., Fujisawa, S., Ogawa, K., Motomura, S., Suzuki, R., Ishigatsubo, Y.: The therapeutic effect of rituximab on CD5-positive and CD5-negative diffuse large B-cell lymphoma.
Hematol Oncol, 28, 27-32 (2010)
Ichinohasama, R., Oji, Y., Yokoyama, H., Takeuchi, K., Fujiwara, T., Ishizawa, K., Taniguchi, O., Tsuboi, A., Oka, Y., Sugiyama, H.: Sensitive immunohistochemical detection of WT1 protein in tumors with anti-WT1 antibody against WT1 235 peptide.
Cancer Sci, 101, 1089-1092 (2010)
Jokoji, R., Yamasaki, T., Minami, S., Komuta, K., Sakamaki, Y., Takeuchi, K., Tsujimoto, M.: Combination of morphological feature analysis and immunohistochemistry is useful for screening of EML4-ALK-positive lung adenocarcinoma.
J Clin Pathol, 63, 1066-1070 (2010)
Kodaira, M., Takahashi, S., Takeuchi, K., Yuasa, T., Saotome, T., Yonese, J., Fukui, I., Hatake, K.: Sorafenib-induced erythema multiforme for metastatic renal cell carcinoma.
Ann Oncol, 21, 1563-1565 (2010)
Kodaira, M., Takahashi, S., Yamada, S., Ueda, K., Mishima, Y., Takeuchi, K., Yamamoto, N., Ishikawa, Y., Yokoyama, M., Saotome, T., Terui, Y., Hatake, K.: Bone metastasis and poor performance status are prognostic factors for survival of carcinoma of unknown primary site in patients treated with systematic chemotherapy.
Ann Oncol, 21, 1163-1167 (2010)
Mano, H., Takeuchi, K.: EML4-ALK fusion in lung.
Am J Pathol, 176, 1552-1553; author reply 1553-1554 (2010)
Nakajima, T., Kimura, H., Takeuchi, K., Soda, M., Mano, H., Yasufuku, K., Iizasa, T.: Treatment of lung cancer with an ALK inhibitor after EML4-ALK fusion gene detection using endobronchial ultrasound-guided transbronchial needle aspiration.
J Thorac Oncol, 5, 2041-2043 (2010)
Nishimori, H., Takahashi, S., Kiura, K., Ennishi, D., Kobayashi, T., Sano, K., Shinozaki, E., Yokoyama, M., Mishima, Y., Terui, Y., Chin, K., Mizunuma, N., Ito, Y., Nishimura, S., Takeuchi, K., Ishikawa, Y., Oguchi, M., Tanimoto, M., Hatake, K.: Cancer of unknown primary site:a review of 28 cases and the efficacy of cisplatin/docetaxel therapy at a single institute in Japan.
Acta Med Okayama, 64, 285-291 (2010)
Sakairi, Y., Nakajima, T., Yasufuku, K., Ikebe, D., Kageyama, H., Soda, M., Takeuchi, K., Itami, M., Iizasa, T., Yoshino, I., Mano, H., Kimura, H.: EML4-ALK fusion gene assessment using metastatic lymph node samples obtained by endobronchial ultrasound-guided transbronchial needle aspiration.
Clin Cancer Res, 16, 4938-4945 (2010)
Takeuchi, K., Yokoyama, M., Ishizawa, S., Terui, Y., Nomura, K., Marutsuka, K., Nunomura, M., Fukushima, N., Yagyuu, T., Nakamine, H., Akiyama, F., Hoshi, K., Matsue, K., Hatake, K., Oshimi, K.: Lymphomatoid gastropathy: a distinct clinicopathologic entity of self-limited pseudomalignant NK-cell proliferation.
Blood, 116, 5631-5637 (2010)
Tsuji, H., Tamura, M., Yokoyama, M., Takeuchi, K., Mimura, T.: Ocular involvement by epstein-barr virus-positive diffuse large B-cell lymphoma of the elderly: a new disease entity in the world health organization classification.
Arch Ophthalmol, 128, 258-259 (2010)
Watanabe, R., Tomita, N., Takeuchi, K., Sakata, S., Tateishi, U., Tanaka, M., Fujita, H., Inayama, Y., Ishigatsubo, Y.: SUVmax in FDG-PET at the biopsy site correlates with the proliferation potential of tumor cells in non-Hodgkin lymphoma.
Leuk Lymphoma, 51, 279-283 (2010)

2009年

Ennishi, D., Yokoyama, M., Terui, Y., Asai, H., Sakajiri, S., Mishima, Y., Takahashi, S., Komatsu, H., Ikeda, K., Takeuchi, K., Tanimoto, M., Hatake, K.: Soluble interleukin-2 receptor retains prognostic value in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP (RCHOP) therapy.
Ann Oncol, 20, 526-533 (2009)
Imai, H., Sugimoto, K., Isobe, Y., Sasaki, M., Yasuda, H., Takeuchi, K., Nakamura, S., Kojima, Y., Tomomatsu, J., Oshimi, K.: Absence of tumor-specific over-expression of Polo-like kinase 1 (Plk1) in major non-Hodgkin lymphoma and relatively low expression of Plk1 in nasal NK/T cell lymphoma.
Int J Hematol, 89, 673-678 (2009)
Inamura, K., Takeuchi, K., Togashi, Y., Hatano, S., Ninomiya, H., Motoi, N., Mun, M.Y., Sakao, Y., Okumura, S., Nakagawa, K., Soda, M., Choi, Y.L., Mano, H., Ishikawa, Y.: EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset.
Mod Pathol, 22, 508-515 (2009)
Kato, M., Sanada, M., Kato, I., Sato, Y., Takita, J., Takeuchi, K., Niwa, A., Chen, Y., Nakazaki, K., Nomoto, J., Asakura, Y., Muto, S., Tamura, A., Iio, M., Akatsuka, Y., Hayashi, Y., Mori, H., Igarashi, T., Kurokawa, M., Chiba, S., Mori, S., Ishikawa, Y., Okamoto, K., Tobinai, K., Nakagama, H., Nakahata, T., Yoshino, T., Kobayashi, Y., Ogawa, S.: Frequent inactivation of A20 in B-cell lymphomas.
Nature, 459, 712-716 (2009)
Kiryu, S., Takeuchi, K., Shibahara, J., Uozaki, H., Fukayama, M., Tanaka, H., Maeda, E., Akahane, M., Ohtomo, K.: Epstein-Barr virus-positive inflammatory pseudotumour and inflammatory pseudotumour-like follicular dendritic cell tumour.
Br J Radiol, 82, e67-71 (2009)
Masuda, S., Ageyama, N., Shibata, H., Obara, Y., Ikeda, T., Takeuchi, K., Ueda, Y., Ozawa, K., Hanazono, Y.: Cotransplantation with MSCs improves engraftment of HSCs after autologous intra-bone marrow transplantation in nonhuman primates.
Exp Hematol, 37, 1250-1257 e1251 (2009)
Mishima, Y., Sugimura, N., Matsumoto-Mishima, Y., Terui, Y., Takeuchi, K., Asai, S., Ennishi, D., Asai, H., Yokoyama, M., Kojima, K., Hatake, K.: An imaging-based rapid evaluation method for complement-dependent cytotoxicity discriminated clinical response to rituximab-containing chemotherapy.
Clin Cancer Res, 15, 3624-3632 (2009)
Nakamura, Y., Migita, T., Hosoda, F., Okada, N., Gotoh, M., Arai, Y., Fukushima, M., Ohki, M., Miyata, S., Takeuchi, K., Imoto, I., Katai, H., Yamaguchi, T., Inazawa, J., Hirohashi, S., Ishikawa, Y., Shibata, T.: Kruppel-like factor 12 plays a significant role in poorly differentiated gastric cancer progression.
Int J Cancer, 125, 1859-1867 (2009)
Takeuchi, K., Choi, Y.L., Togashi, Y., Soda, M., Hatano, S., Inamura, K., Takada, S., Ueno, T., Yamashita, Y., Satoh, Y., Okumura, S., Nakagawa, K., Ishikawa, Y., Mano, H.: KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer.
Clin Cancer Res, 15, 3143-3149 (2009)
Tanaka, Y., Ikeda, T., Kishi, Y., Masuda, S., Shibata, H., Takeuchi, K., Komura, M., Iwanaka, T., Muramatsu, S., Kondo, Y., Takahashi, K., Yamanaka, S., Hanazono, Y.: ERas is expressed in primate embryonic stem cells but not related to tumorigenesis.
Cell Transplant, 18, 381-389 (2009)
Terui, Y., Mishima, Y., Sugimura, N., Kojima, K., Sakurai, T., Kuniyoshi, R., Taniyama, A., Yokoyama, M., Sakajiri, S., Takeuchi, K., Watanabe, C., Takahashi, S., Ito, Y., Hatake, K.: Identification of CD20 C-terminal deletion mutations associated with loss of CD20 expression in non-Hodgkin's lymphoma.
Clin Cancer Res, 15, 2523-2530 (2009)
Tomita, N., Takeuchi, K., Hyo, R., Hashimoto, C., Takemura, S., Taguchi, J., Fujita, H., Fujisawa, S., Ogawa, K., Motomura, S., Ishigatsubo, Y.: Diffuse large B cell lymphoma without immunoglobulin light chain restriction by flow cytometry.
Acta Haematol, 121, 196-201 (2009)
Tomita, N., Tokunaka, M., Nakamura, N., Takeuchi, K., Koike, J., Motomura, S., Miyamoto, K., Kikuchi, A., Hyo, R., Yakushijin, Y., Masaki, Y., Fujii, S., Hayashi, T., Ishigatsubo, Y., Miura, I.: Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations.
Haematologica, 94, 935-943 (2009)
Yano, S., Usui, N., Dobashi, N., Yahagi, Y., Takahara, S., Sugiyama, K., Ogasawara, Y., Saito, T., Minami, J., Kobayashi, T., Nikaido, T., Takeuchi, K., Aiba, K.: A case of primary esophageal mucosa-associated lymphoid tissue lymphoma with a numerical abnormality of 18q21 detected by fluorescence in situ hybridization.
Ann Hematol, 88, 703-704 (2009)
Yoshimura, K., Takeuchi, K., Nagasaki, K., Ogishima, S., Tanaka, H., Iwase, T., Akiyama, F., Kuroda, Y., Miki, Y.: Prognostic value of matrix Gla protein in breast cancer.
Mol Med Rep, 2, 549-553 (2009)

2008年

Choi, Y.L., Takeuchi, K., Soda, M., Inamura, K., Togashi, Y., Hatano, S., Enomoto, M., Hamada, T., Haruta, H., Watanabe, H., Kurashina, K., Hatanaka, H., Ueno, T., Takada, S., Yamashita, Y., Sugiyama, Y., Ishikawa, Y., Mano, H.: Identification of novel isoforms of the EML4-ALK transforming gene in non-small cell lung cancer.
Cancer Res, 68, 4971-4976 (2008)
Ennishi, D., Takeuchi, K., Yokoyama, M., Asai, H., Mishima, Y., Terui, Y., Takahashi, S., Komatsu, H., Ikeda, K., Yamaguchi, M., Suzuki, R., Tanimoto, M., Hatake, K.: CD5 expression is potentially predictive of poor outcome among biomarkers in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy.
Ann Oncol, 19, 1921-1926 (2008)
Ennishi, D., Terui, Y., Yokoyama, M., Mishima, Y., Takahashi, S., Takeuchi, K., Ikeda, K., Tanimoto, M., Hatake, K.: Increased incidence of interstitial pneumonia by CHOP combined with rituximab.
Int J Hematol, 87, 393-397 (2008)
Ennishi, D., Terui, Y., Yokoyama, M., Mishima, Y., Takahashi, S., Takeuchi, K., Okamoto, H., Tanimoto, M., Hatake, K.: Monitoring serum hepatitis C virus (HCV) RNA in patients with HCV-infected CD20-positive B-cell lymphoma undergoing rituximab combination chemotherapy.
Am J Hematol, 83, 59-62 (2008)
Ennishi, D., Yokoyama, M., Terui, Y., Takeuchi, K., Ikeda, K., Tanimoto, M., Hatake, K.: Does rituximab really induce hepatitis C virus reactivation?
J Clin Oncol, 26, 4695-4696; author reply 4696 (2008)
Inamura, K., Takeuchi, K., Togashi, Y., Nomura, K., Ninomiya, H., Okui, M., Satoh, Y., Okumura, S., Nakagawa, K., Soda, M., Choi, Y.L., Niki, T., Mano, H., Ishikawa, Y.: EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers.
J Thorac Oncol, 3, 13-17 (2008)
Izawa, N., Matsumoto, S., Manabe, J., Tanizawa, T., Hoshi, M., Shigemitsu, T., Machinami, R., Kanda, H., Takeuchi, K., Miki, Y., Arai, M., Shirahama, S., Kawaguchi, N.: A Japanese patient with Li-Fraumeni syndrome who had nine primary malignancies associated with a germline mutation of the p53 tumor-suppressor gene.
Int J Clin Oncol, 13, 78-82 (2008)
Machinami, R., Nishida, K., Ishida, T., Matsumoto, S., Kuroda, K., Kobayashi, M., Takeuchi, K., Ishikawa, Y.: Carcinosarcomatous malignancy, osteosarcoma and squamous cell carcinoma, in giant cell tumor of the right distal femur.
Pathol Res Pract, 204, 583-588 (2008)
Soda, M., Takada, S., Takeuchi, K., Choi, Y.L., Enomoto, M., Ueno, T., Haruta, H., Hamada, T., Yamashita, Y., Ishikawa, Y., Sugiyama, Y., Mano, H.: A mouse model for EML4-ALK-positive lung cancer.
Proc Natl Acad Sci U S A, 105, 19893-19897 (2008)
Suzuki, N., Katsusihma, H., Takeuchi, K., Nakamura, S., Ishizawa, K., Ishii, S., Moriya, T., DeCoteau, J.F., Miura, I., Ichinohasama, R.: Cytogenetic abnormality 46,XX,add(21)(q11.2) in a patient with follicular dendritic cell sarcoma.
Cancer Genet Cytogenet, 186, 54-57 (2008)
Suzuki, R., Takeuchi, K., Ohshima, K., Nakamura, S.: Extranodal NK/T-cell lymphoma: diagnosis and treatment cues.
Hematol Oncol, 26, 66-72 (2008)
Takeuchi, K., Choi, Y.L., Soda, M., Inamura, K., Togashi, Y., Hatano, S., Enomoto, M., Takada, S., Yamashita, Y., Satoh, Y., Okumura, S., Nakagawa, K., Ishikawa, Y., Mano, H.: Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts.
Clin Cancer Res, 14, 6618-6624 (2008)

2007年

Ennishi, D., Yokoyama, M., Mishima, Y., Watanabe, C., Terui, Y., Takahashi, S., Takeuchi, K., Ikeda, K., Tanimoto, M., Hatake, K.: Rituximab plus CHOP as an initial chemotherapy for patients with disseminated MALT lymphoma.
Leuk Lymphoma, 48, 2241-2243 (2007)
Isobe, Y., Sugimoto, K., Takeuchi, K., Ando, J., Masuda, A., Mori, T., Oshimi, K.: Neural cell adhesion molecule (CD56)-positive B-cell lymphoma.
Eur J Haematol, 79, 166-169 (2007)
Narimatsu, H., Ota, Y., Kami, M., Takeuchi, K., Suzuki, R., Matsuo, K., Matsumura, T., Yuji, K., Kishi, Y., Hamaki, T., Sawada, U., Miyata, S., Sasaki, T., Tobinai, K., Kawabata, M., Atsuta, Y., Tanaka, Y., Ueda, R., Nakamura, S.: Clinicopathological features of pyothorax-associated lymphoma; a retrospective survey involving 98 patients.
Ann Oncol, 18, 122-128 (2007)
Nitta, E., Izutsu, K., Sato, T., Ota, Y., Takeuchi, K., Kamijo, A., Takahashi, K., Oshima, K., Kanda, Y., Chiba, S., Motokura, T., Kurokawa, M.: A high incidence of late-onset neutropenia following rituximab-containing chemotherapy as a primary treatment of CD20-positive B-cell lymphoma: a single-institution study.
Ann Oncol, 18, 364-369 (2007)
Oyama, T., Yamamoto, K., Asano, N., Oshiro, A., Suzuki, R., Kagami, Y., Morishima, Y., Takeuchi, K., Izumo, T., Mori, S., Ohshima, K., Suzumiya, J., Nakamura, N., Abe, M., Ichimura, K., Sato, Y., Yoshino, T., Naoe, T., Shimoyama, Y., Kamiya, Y., Kinoshita, T., Nakamura, S.: Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients.
Clin Cancer Res, 13, 5124-5132 (2007)
Sakoda, Y., Hashimoto, D., Asakura, S., Takeuchi, K., Harada, M., Tanimoto, M., Teshima, T.: Donor-derived thymic-dependent T cells cause chronic graft-versus-host disease.
Blood, 109, 1756-1764 (2007)
Shinohara, A., Asai, T., Izutsu, K., Ota, Y., Takeuchi, K., Hangaishi, A., Kanda, Y., Chiba, S., Motokura, T., Kurokawa, M.: Durable remission after the administration of rituximab for EBV-negative, diffuse large B-cell lymphoma following autologous peripheral blood stem cell transplantation for angioimmunoblastic T-cell lymphoma.
Leuk Lymphoma, 48, 418-420 (2007)
Tomita, N., Motomura, S., Hyo, R., Takasaki, H., Takemura, S., Taguchi, J., Fujisawa, S., Ogawa, K., Ishigatsubo, Y., Takeuchi, K.: Comparison of peripheral T-cell lymphomas and diffuse large B-cell lymphoma.
Cancer, 109, 1146-1151 (2007)

2006年

Hoshi, M., Matsumoto, S., Manabe, J., Tanizawa, T., Shigemitsu, T., Izawa, N., Takeuchi, K., Kawaguchi, N.: Malignant change secondary to fibrous dysplasia.
Int J Clin Oncol, 11, 229-235 (2006)
Hoshi, M., Matsumoto, S., Manabe, J., Tanizawa, T., Shigemitsu, T., Koyanagi, H., Ae, K., Takeuchi, K., Kawaguchi, N.: Surgery for dedifferentiated liposarcoma, presenting two radiologically and pathologically distinctive patterns.
Jpn J Clin Oncol, 36, 462-467 (2006)
Hoshi, M., Matsumoto, S., Manabe, J., Tanizawa, T., Shigemitsu, T., Takeuchi, K., Kawaguchi, N.: Report of four cases with high-grade surface osteosarcoma.
Jpn J Clin Oncol, 36, 180-184 (2006)
Hoshi, M., Matsumoto, S., Manabe, J., Tanizawa, T., Shigemitsu, T., Takeuchi, K., Kawaguchi, N.: Three cases with periosteal osteosarcoma arising from the femur.
J Orthop Sci, 11, 224-228 (2006)
Iwata, H., Matsuo, K., Hara, S., Takeuchi, K., Aoyama, T., Murashige, N., Kanda, Y., Mori, S., Suzuki, R., Tachibana, S., Yamane, M., Odawara, M., Mutou, Y., Kami, M.: Use of hydroxy-methyl-glutaryl coenzyme A reductase inhibitors is associated with risk of lymphoid malignancies.
Cancer Sci, 97, 133-138 (2006)
Kim, S.W., Tanimoto, T.E., Hirabayashi, N., Goto, S., Kami, M., Yoshioka, S., Uchida, T., Kishi, K., Tanaka, Y., Kohno, A., Kasai, M., Higuchi, M., Mori, S., Fukuda, T., Izutsu, K., Sao, H., Ishikawa, T., Ichinohe, T., Takeuchi, K., Tajima, K., Tanosaki, R., Harada, M., Taniguchi, S., Tobinai, K., Hotta, T., Takaue, Y.: Myeloablative allogeneic hematopoietic stem cell transplantation for non-Hodgkin lymphoma: a nationwide survey in Japan.
Blood, 108, 382-389 (2006)
Kiryu, S., Okubo, T., Takeuchi, K., Inoue, Y., Endo, T., Odawara, T., Nakamura, T., Aoki, S., Ohtomo, K.: Magnetic resonance imaging and diffusion tensor analysis of lymphomatoid granulomatosis of the brain.
Acta Radiol, 47, 509-513 (2006)
Mito, H., Kakizaki, H., Tsuji, H., Ide, A., Takeuchi, K., Takamura, H.: Peripheral T-cell lymphoma of the eyelid.
Jpn J Ophthalmol, 50, 388-390 (2006)
Shi, X., Matsumoto, S., Manbe, J., Tanizawa, T., Hoshi, M., Sigemitsu, T., Izawa, N., Takeuchi, K., Kawaguchi, N.: Long-term survival of soft tissue sarcoma patients with extrapulmonary metastasis.
J Orthop Sci, 11, 92-96 (2006)
Takeuchi, K., Tanaka-Taya, K., Kazuyama, Y., Ito, Y.M., Hashimoto, S., Fukayama, M., Mori, S.: Prevalence of Epstein-Barr virus in Japan: trends and future prediction.
Pathol Int, 56, 112-116 (2006)

目次

原著論文

2012年

2011年

2010年

2009年

2008年

2007年

2006年